前列腺导管内癌的特征与预后意义
本文综述前列腺导管内癌(IDC-P)的病理与遗传特征、诊断标准与鉴别诊断及临床意义。IDC-P与高Gleason评分/分级分组、大肿瘤体积的侵袭性前列腺癌强相关,预后不良;活检中孤立性IDC-P罕见,但此类患者推荐接受根治性治疗或立即重复活检。
要点
- IDC-P是独立实体,形态学与遗传学特征独特,与高Gleason评分/分级分组及大肿瘤体积强相关。
- 已建立形态学诊断标准以区别于组织学相似的其他病变。
- 活检中孤立性IDC-P患者推荐接受根治性治疗或立即重复活检。
核心结论
- 识别并报告IDC-P至关重要,尤其在前列腺活检中其临床影响最大。
研究设计与样本
- 综述:检索PubMed,关键词包括前列腺癌、导管内癌、IDC、组织学、诊断标准与预后,并查阅相关文献的参考文献。
主要发现
- IDC-P是独立实体,具有特征性形态学与遗传学特征,与高Gleason评分/分级分组及大肿瘤体积的侵袭性前列腺癌强相关,并预示不良临床结局。
- 已建立形态学诊断标准以区别于组织学特征相似的其他病变。
- IDC-P在前列腺活检中不常见,作为不伴前列腺癌的孤立性发现更为罕见。
关键数值与推荐
- IDC-P定义为腺上皮细胞的腺内/导管内肿瘤性生长,特征为腺体结构显著异常和/或细胞学异型性超出高级别前列腺上皮内瘤变(HPGIN)的典型表现。
- 活检标本中孤立性IDC-P患者推荐接受根治性治疗或立即重复活检。
临床怎么用
- 病理学家应在前列腺标本中识别并报告IDC-P,尤其在前列腺活检中,以辅助患者管理。
- 活检中孤立性IDC-P患者推荐接受根治性治疗或立即重复活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Intraductal carcinoma of the prostate (IDC-P) is an intraglandular/ductal neoplastic growth of glandular epithelial cells characterized by marked abnormality of the glandular architecture and/or cytological atypia that exceeds what is typically seen in high-grade prostatic intraepithelial neoplasia (HPGIN). It has been shown that IDC-P is a strong independent indicator of poor prognosis for prostate carcinoma (PCa). OBJECTIVE: To review the pathological and genetic features, diagnostic criteria and differential diagnosis, and clinical significance of IDC-P. EVIDENCE ACQUISITION: PubMed was searched using keywords including prostate carcinoma, intraductal carcinoma, IDC, histology, diagnostic criteria, and prognosis. The references in relevant articles were also reviewed. EVIDENCE SYNTHESIS: IDC-P is a distinct entity with characteristic morphological and genetic features. It is strongly associated with aggressive PCa with high Gleason score/grade groups and large tumor volume, and portends unfavorable clinical outcomes. Morphological diagnostic criteria have been established to distinguish it from other lesions with similar histological features. IDC-P is an uncommon finding in prostate biopsies, and is even rarer as an isolated finding without concomitant PCa. However, patients with isolated IDC-P in biopsy specimens are recommended to have either definitive treatment or immediate repeat biopsy. CONCLUSIONS: It is critical to recognize and report IDC-P, especially in prostate biopsies, where the clinical impact of such a diagnosis is greatest. PATIENT SUMMARY: Intraductal carcinoma is a unique form of aggressive prostate cancer. In this report, we review its pathological and genetic features and poor prognostic significance. It is critical for pathologists to recognize and report this lesion in prostate specimens, especially in prostate biopsies for patient management.
引用
- Montironi R, Zhou M, Magi-Galluzzi C, et al. Features and Prognostic Significance of Intraductal Carcinoma of the Prostate. Eur Urol Oncol. 2018. PMID: 31100224. doi:10.1016/j.euo.2018.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。